Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | VNOVVitaNova Life Sciences CorpFY2026 · Apr |
|---|---|
| Revenue | $3.03M |
| Revenue, yoy | +13.7% |
| Net income | $37.30K |
| Net income, yoy | −104.4% |
| Net margin | -1.2% |
| Free cash flow | — |
| FCF margin | — |
| EPS, diluted | $0.03 |
Add another company.